Only 2 New Alzheimer’s Drugs Approved in 20 Years: What’s Going Wrong?
Despite $2.6 billion in funding, only 2 new Alzheimer’s drugs were approved in two decades, highlighting systemic failures in biotech.
biotech failures
Despite $2.6 billion in funding, only 2 new Alzheimer’s drugs were approved in two decades, highlighting systemic failures in biotech.